Dr. Hasan Berkay Ozdegirmenci, MD

Dr. Ozdegirmenci practices at Ascension Saint Thomas Rutherford in Murfreesboro, Tennessee, part of Ascension Health Alliance.

Dr. Ozdegirmenci's NPI, 1366642415, was assigned on July 18, 2007. Dr. Ozdegirmenci holds Tennessee license 54842.

Dr. Ozdegirmenci's primary practice is Ascension Saint Thomas Rutherford, at 1700 Medical Center Parkway, Murfreesboro, TN 37129 in Rutherford County. The practice phone is (615) 396-4100.

Dr. Ozdegirmenci's primary practice is Ascension Saint Thomas Rutherford in Murfreesboro, Tennessee, part of Ascension Health Alliance. Dr. Ozdegirmenci is also affiliated with Ascension Saint Thomas Hospital West. The medical group on file is Ascension Saint Thomas Medical Partners. Dmand AI also links Dr. Ozdegirmenci to 3 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ozdegirmenci practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Ozdegirmenci's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Ozdegirmenci's licenses on file in 2 states: Tennessee and Texas.

CMS data shows 619 Medicare services from Dr. Ozdegirmenci across 4 procedure codes in 2024, for 266 Medicare patients. Medicare paid $52,689 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 266 Medicare patients who saw Dr. Ozdegirmenci in 2024. The largest group is 75 to 84, with 100 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.40, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ozdegirmenci's median patient age at 73, with 51% women.

In 2024, Dr. Ozdegirmenci wrote 362 Medicare Part D claims for 157 patients. 86% of them were for generic drugs. CMS names the drug for 120 of them, across 8 drugs with 11 or more claims each, at $928 in total drug cost. In 2023, CMS named 85 claims across 5 drugs.

Dr. Ozdegirmenci accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ozdegirmenci as offering telehealth.

CMS Open Payments shows 2 general payments to Dr. Ozdegirmenci from 2 drug and device companies in 2016. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $109.